OBJECTIVES. There is concern that financial incentives in health maint
enance organizations (HMOs) might result in pressures to induce sicker
members to disenroll. The authors compared disenrollment rates of Med
icare HMO enrollees with cancer with disenrollment rates for cancer-fr
ee enrollees, using Medicare enrollment files linked to population-bas
ed tumor registry data from the Surveillance, Epidemiology, and End Re
sults (SEER) Program. METHODS. The authors identified all aged Medicar
e beneficiaries who enrolled in an HMO located in a SEER reporting are
a during 1985 to 1989. Time to disenrollment was analyzed using a prop
ortional hazards model. RESULTS. Overall, cancer patients were no more
likely to disenroll than others. However, persons diagnosed with canc
er after enrollment were less likely to disenroll. than other persons
in Independent practice Association (IPA) model HMOs (relative risk [R
R] = 0.79). Persons diagnosed with cancer after enrollment in group- a
nd staff-model HMOs were about equally likely to disenroll as other pe
rsons (RR = 0.91). Persons diagnosed with cancer less than 18 months b
efore enrollment were at high risk for disenrollment from both IPA and
group-/staff-model HMOs (RR = 1.47 and 1.35). There was substantial v
ariation among HMOs in overall disenrollment rates and in RRs for dise
nrollment by cancer patients. CONCLUSIONS. The low disenrollment rates
of patients diagnosed after enrollment do not support the contention
that features intrinsic to managed care make HMOs unattractive to the
seriously ill. Monitoring of selective disenrollment could be used as
a screen for possible access and quality problems.